Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the study of ANCA-Associated Vasculitis, specifically mentioning the drug Rituximab and the revision of the study version to v2.15.0. Additionally, significant details regarding the study's design and methodology have been removed.SummaryDifference11%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 24, 2025.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 24, 2025.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has updated its last update date to March 2025 and included information about a study acquired by Amgen, indicating a change in sponsorship.SummaryDifference0.7%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.